The long-term goal of the Clinical Core is to provide the expertise and infrastructure to assure the completion of all of the patient-based research studies proposed in this SPORE grant. The core goals will be achieved through accomplishing the following aims: 1. Assess the status of APC gene and ODC gene promoter in patients with colorectal adenomas participating in chemoprevention trials (Principal Investigator-David Alberts, M.D.). 2. Evaluate clinical activity of cycloxygenase inhibitor celecoxib in reversing Barrett?s esophagus as premalignant lesion in a phase II clinical trial (Principal Investigator-Harinder Garewal, M.D.). 3. Conduct pilot studies of vaccination with dendritic cells expressing MUC1-fusion proteins in patients with gastrointestinal malignancies (Principal Investigator-Evan Hersh, M.D.). 4. Evaluate new thioredoxin-1 inhibitor PX-12 in a phase II clinical trial in patients with colorectal cancer (Principal Investigator-Tomislav Dragovich, M.D., Ph.D.) 5. Evaluate clinical activity of C-myc inhibitors in patients with pancreatic and colorectal cancers (Principal Investigator-Daniel D. Von Hoff M.D.). 6. Design and conduct clinical trials with new target-based treatments validated through our developmental projects (for example-new urokinase inhibitors, hypomethylating agents). We intend to accomplish these aims by assembling a team of expert clinical investigators and clinical research staff that will complement already existing clinical research effort here at the University of Arizona/Arizona Cancer Center. This resource core will be devoted to development and evaluation of new treatment approaches for patients with gastrointestinal malignancies. The core will supervise design and conduct of clinical trials for patients with gastrointestinal cancer, facilitate acquisition of pharmacokinetic and pharmacodynamic data, and supervise and facilitate acquisition of biologic samples from patients participating in clinical trials.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
1P50CA095060-01
Application #
6666183
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2002-09-05
Project End
2007-03-31
Budget Start
Budget End
Support Year
1
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Arizona
Department
Type
DUNS #
City
Tucson
State
AZ
Country
United States
Zip Code
85722
Goldenberg, Joshua M; Pagel, Mark D; Cárdenas-Rodríguez, Julio (2018) Characterization of D-maltose as a T2 -exchange contrast agent for dynamic contrast-enhanced MRI. Magn Reson Med 80:1158-1164
Jones, Kyle M; Pollard, Alyssa C; Pagel, Mark D (2018) Clinical applications of chemical exchange saturation transfer (CEST) MRI. J Magn Reson Imaging 47:11-27
Goldenberg, Joshua M; Cárdenas-Rodríguez, Julio; Pagel, Mark D (2018) Preliminary Results that Assess Metformin Treatment in a Preclinical Model of Pancreatic Cancer Using Simultaneous [18F]FDG PET and acidoCEST MRI. Mol Imaging Biol 20:575-583
Daryaei, Iman; Randtke, Edward A; Pagel, Mark D (2017) A biomarker-responsive T2exMRI contrast agent. Magn Reson Med 77:1665-1670
Daryaei, Iman; Jones, Kyle M; Pagel, Mark D (2017) Detection of DT-diaphorase Enzyme with a ParaCEST MRI Contrast Agent. Chemistry 23:6514-6517
Shkreta, Lulzim; Blanchette, Marco; Toutant, Johanne et al. (2017) Modulation of the splicing regulatory function of SRSF10 by a novel compound that impairs HIV-1 replication. Nucleic Acids Res 45:4051-4067
Liu, Lin; Messer, Karen; Baron, John A et al. (2016) A prognostic model for advanced colorectal neoplasia recurrence. Cancer Causes Control 27:1175-85
Harpel, Kaitlin; Leung, Sarah; Rice, Photini Faith et al. (2016) Imaging colon cancer development in mice: IL-6 deficiency prevents adenoma in azoxymethane-treated Smad3 knockouts. Phys Med Biol 61:N60-9
Chang, Hae Ryung; Nam, Seungyoon; Kook, Myeong-Cherl et al. (2016) HNF4? is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer. Gut 65:19-32
Daryaei, Iman; Ghaffari, Mahsa Mohammadebrahim; Jones, Kyle M et al. (2016) Detection of Alkaline Phosphatase Enzyme Activity with a CatalyCEST MRI Biosensor. ACS Sens 1:857-861

Showing the most recent 10 out of 239 publications